Azenta, Inc. (NASDAQ:AZTA) Shares Purchased by Farther Finance Advisors LLC

Farther Finance Advisors LLC grew its stake in shares of Azenta, Inc. (NASDAQ:AZTA) by 20.0% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,537 shares of the company’s stock after acquiring an additional 256 shares during the quarter. Farther Finance Advisors LLC’s holdings in Azenta were worth $74,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of AZTA. Dimensional Fund Advisors LP increased its position in Azenta by 16.5% during the second quarter. Dimensional Fund Advisors LP now owns 2,970,964 shares of the company’s stock worth $156,331,000 after purchasing an additional 421,719 shares during the last quarter. Allspring Global Investments Holdings LLC grew its stake in shares of Azenta by 16.4% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 1,298,856 shares of the company’s stock valued at $62,917,000 after buying an additional 183,040 shares during the period. Kayne Anderson Rudnick Investment Management LLC increased its holdings in shares of Azenta by 1.9% during the 2nd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 5,298,040 shares of the company’s stock worth $278,783,000 after buying an additional 100,826 shares during the last quarter. Squarepoint Ops LLC raised its position in shares of Azenta by 433.6% in the 2nd quarter. Squarepoint Ops LLC now owns 73,055 shares of the company’s stock worth $3,844,000 after buying an additional 59,364 shares during the period. Finally, Edgestream Partners L.P. raised its position in shares of Azenta by 618.2% in the 1st quarter. Edgestream Partners L.P. now owns 58,644 shares of the company’s stock worth $3,535,000 after buying an additional 50,479 shares during the period. 99.08% of the stock is currently owned by hedge funds and other institutional investors.

Azenta Price Performance

NASDAQ:AZTA opened at $45.99 on Wednesday. Azenta, Inc. has a 12 month low of $40.24 and a 12 month high of $69.16. The business’s 50-day moving average is $45.83 and its two-hundred day moving average is $50.64. The firm has a market capitalization of $2.25 billion, a PE ratio of -16.37 and a beta of 1.48.

Analyst Upgrades and Downgrades

AZTA has been the subject of several research analyst reports. Needham & Company LLC restated a “buy” rating and set a $69.00 price target on shares of Azenta in a research note on Wednesday, August 7th. Evercore ISI dropped their target price on shares of Azenta from $53.00 to $50.00 and set an “in-line” rating for the company in a research report on Tuesday, October 1st. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $66.40.

Insider Activity at Azenta

In other Azenta news, CFO Herman Cueto sold 1,595 shares of the company’s stock in a transaction that occurred on Thursday, October 17th. The stock was sold at an average price of $43.68, for a total value of $69,669.60. Following the completion of the transaction, the chief financial officer now owns 24,604 shares in the company, valued at $1,074,702.72. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 1.77% of the company’s stock.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.